October 25/New York/Wall Street Journal -- Royal DSM has agreed to buy Cargill Inc.'s cultures and enzymes business for 85 million euros ($109.7 million) in cash, as the Netherlands-based company looks to expand in the global dairy market.
DSM said combining Cargill's cultures and enzymes business with its dairy business will allow it "to propel sales growth as well as capture sizable synergies in global manufacturing and customer reach as well as innovation capabilities in biotechnology and SG&A."